Published Jun 13, 2021

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more

Delve into the billionaire space race's implications for industry transformation, unravel the complexities of remote work dynamics and wealth taxation, and critically examine the controversial FDA approval of Biogen's Alzheimer's drug, highlighting its impact on regulatory and economic practices.
Episode Highlights
All-In Podcast logo

Popular Clips

Episode Highlights

Related Episodes